Lidocaine patch 1.8%

DRUG2 trials

Sponsors

Scilex Pharmaceuticals, Inc.

Conditions

Healthy

Phase 1

Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

CompletedNCT04144192

Scilex Pharmaceuticals, Inc.Healthy

Start: 2014-04-28End: 2014-07-24Updated: 2024-05-23

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects

CompletedNCT04320173

Scilex Pharmaceuticals, Inc.Healthy

Start: 2017-02-14End: 2017-03-22Updated: 2020-03-24

Related Papers

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects

Journal of Pain Research2021-02-017 citations

<p>A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects</p>

Journal of Pain Research2020-06-0111 citations